Literature DB >> 109414

Umbilical vein as ureteral replacement.

K F Klippel, R Hohenfellner.   

Abstract

In 13 dogs the middle one-third of the ureter and in four dogs the entire ureter was replaced by fresh Rhesus monkey or human umbilical cord vein. The overall success rate was 60 per cent (10/17); one dog revealed an excellent intravenous pyelogram; the typical roentgenographic appearance of the kidney was a slight hydronephrosis. Animals surviving for more than 1 year were nephrectomized on the contralateral side. One dog is still alive at 36 months. Histologically, the typical structures of the umbilical vein remained unchanged after 2 years, but endothelium was replaced by urothelium. The umbilical vein seems to be an embryonic tissue of extremely low antigenicity and therefore suitable for transplantation.

Entities:  

Mesh:

Year:  1979        PMID: 109414

Source DB:  PubMed          Journal:  Invest Urol        ISSN: 0021-0005


  4 in total

1.  Ureteral replacement in the dog using ethanol preserved glutaraldehyde umbilical vein.

Authors:  M G Donovan; P A McLean
Journal:  Ir J Med Sci       Date:  1982-01       Impact factor: 1.568

2.  The feasibility of ureteral tissue engineering using autologous veins: an orthotopic animal model with long term results.

Authors:  Oliver Engel; Robert de Petriconi; Björn G Volkmer; Kilian M Gust; Jens Mani; Axel Haferkamp; Richard E Hautmann; Georg Bartsch
Journal:  J Negat Results Biomed       Date:  2014-11-08

Review 3.  Artificial urinary conduit construction using tissue engineering methods.

Authors:  Tomasz Kloskowski; Marta Pokrywczyńska; Tomasz Drewa
Journal:  Cent European J Urol       Date:  2014-12-31

4.  Ureter regeneration-the proper scaffold has to be defined.

Authors:  Tomasz Kloskowski; Arkadiusz Jundziłł; Tomasz Kowalczyk; Maciej Nowacki; Magdalena Bodnar; Andrzej Marszałek; Marta Pokrywczyńska; Małgorzata Frontczak-Baniewicz; Tomasz A Kowalewski; Piotr Chłosta; Tomasz Drewa
Journal:  PLoS One       Date:  2014-08-27       Impact factor: 3.240

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.